METTL3 and acute myeloid leukemia: Moreover, METTL3 inhibited expression of AKT protein in BMSCs by mediating m6A RNA methylation of AKT1, thus reducing MSC adipogenesis and alleviating chemoresistance in AML cells (Pan et al., 2021).